Lansoprazole Sun Pharma Uk

Lansoprazole, the active ingredient in Lansoprazole Sun Pharma Uk, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease and related disorders.

GNH USA supplies Lansoprazole Sun Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑esophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation. - Peptic ulcer disease: promotes ulcer healing by decreasing gastric acidity. - Erosive esophagitis: allows damaged esophageal tissue to heal by limiting acid injury. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy by suppressing acid production.

Lansoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may improve with continued therapy. - Nausea: feeling of queasiness, sometimes accompanied by mild stomach upset. - Abdominal pain: discomfort or cramping in the upper abdomen. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements or hard stools.

Serious or Rare Side Effects: - Severe allergic reactions: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhea with possible colitis. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Elevated liver enzymes: signs of hepatic stress, monitored via blood tests. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Pancreatitis: upper abdominal pain radiating to the back, often with nausea.

Before initiating therapy, consider the following safety measures.

- Renal function assessment: adjust use in patients with severe renal impairment. - Elderly patients: monitor for increased sensitivity to side effects. - Magnesium monitoring: prolonged use may lead to hypomagnesemia; check levels periodically. - Long‑term use: evaluate necessity regularly to avoid unnecessary exposure. - Concomitant medication review: assess for potential drug‑drug interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole can affect the absorption and metabolism of several medicines.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption; avoid co‑administration. - Atazanavir: decreased antiviral efficacy due to higher gastric pH. - Rilpivirine: diminished HIV‑1 treatment effect; avoid together.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in anticoagulant effect; monitor INR. - Digoxin: enhanced serum levels; watch for toxicity signs. - Methotrexate: reduced clearance may raise toxicity risk. - Clopidogrel: decreased antiplatelet activity; consider alternative. - HIV protease inhibitors (e.g., darunavir): altered plasma concentrations; adjust dosing as needed.